{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:02:46Z","timestamp":1790416966062,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue des Maladies Respiratoires"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.rmr.2017.11.005","type":"journal-article","created":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T01:19:19Z","timestamp":1519867159000},"page":"160-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["La maladie veino-occlusive pulmonaire"],"prefix":"10.1016","volume":"35","author":[{"given":"A.","family":"Boucly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Girerd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Bourlier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Nemlaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Caliez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Savale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Ja\u00efs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Dorfm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Simonneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Sitbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Montani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmr.2017.11.005_bib0280","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1183\/13993003.01032-2015","volume":"46","author":"Gali\u00e8","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2017.11.005_bib0285","first-page":"100","article-title":"Zur histologie der klinischen \u00ab\u00a0primaren pulmonalsklerose\u00a0\u00bb. On the histology of clinical primary pulmonary sclerosis","volume":"47","author":"Hora","year":"1934","journal-title":"Frankfurt Z Path"},{"key":"10.1016\/j.rmr.2017.11.005_bib0290","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1183\/09031936.00090608","article-title":"Pulmonary veno-occlusive disease","volume":"33","author":"Montani","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2017.11.005_bib0295","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1164\/ajrccm.162.5.9912045","article-title":"Pulmonary veno-occlusive disease","volume":"162","author":"Mandel","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2017.11.005_bib0300","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1183\/13993003.00026-2016","article-title":"Pulmonary veno-occlusive disease","volume":"47","author":"Montani","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2017.11.005_bib0305","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1161\/CIRCULATIONAHA.115.014207","article-title":"Mitomycin-induced pulmonary veno-occlusive disease: evidence from human disease and animal models","volume":"132","author":"Perros","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.rmr.2017.11.005_bib0310","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/ng.2844","article-title":"EIF2AK4\u00a0mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension","volume":"46","author":"Eyries","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.rmr.2017.11.005_bib0315","doi-asserted-by":"crossref","first-page":"25S","DOI":"10.1016\/j.jacc.2004.02.033","article-title":"Pathologic assessment of vasculopathies in pulmonary hypertension","volume":"43","author":"Pietra","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rmr.2017.11.005_bib0320","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF01230858","article-title":"The pathology of pulmonary veno-occlusive disease","volume":"364","author":"Wagenvoort","year":"1974","journal-title":"Virchows Arch A Pathol Anat Histol"},{"key":"10.1016\/j.rmr.2017.11.005_bib0325","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1097\/01.pas.0000209834.69972.e5","article-title":"Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis: a clinicopathologic study of 35\u00a0cases","volume":"30","author":"Lantu\u00e9joul","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.rmr.2017.11.005_bib0330","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1183\/09031936.06.00054105","article-title":"Occult alveolar haemorrhage in pulmonary veno-occlusive disease","volume":"27","author":"Rabiller","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2017.11.005_bib0335","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1183\/13993003.00717-2015","article-title":"Genetic counselling in a national referral centre for pulmonary hypertension","volume":"47","author":"Girerd","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2017.11.005_bib0340","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S2213-2600(16)30438-6","article-title":"Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study","volume":"5","author":"Montani","year":"2017","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.rmr.2017.11.005_bib0345","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/cge.12549","article-title":"A founder EIF2AK4\u00a0mutation causes an aggressive form of pulmonary arterial hypertension in Iberian Gypsies","volume":"88","author":"Tenorio","year":"2015","journal-title":"Clin Genet"},{"key":"10.1016\/j.rmr.2017.11.005_bib0350","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/MD.0b013e31818193bb","article-title":"Pulmonary veno-occlusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24\u00a0cases confirmed by histology","volume":"87","author":"Montani","year":"2008","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rmr.2017.11.005_bib0355","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ajpath.2014.10.021","article-title":"Chemotherapy-induced pulmonary hypertension: role of alkylating agents","volume":"185","author":"Ranchoux","year":"2015","journal-title":"Am J Pathol"},{"key":"10.1016\/j.rmr.2017.11.005_bib0360","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1183\/13993003.00814-2015","article-title":"Occupational exposure to organic solvents: a risk factor for pulmonary veno-occlusive disease","volume":"46","author":"Montani","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2017.11.005_bib0365","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1161\/01.CIR.88.5.2149","article-title":"Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults","volume":"88","author":"Celermajer","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.rmr.2017.11.005_bib0370","doi-asserted-by":"crossref","first-page":"997","DOI":"10.3109\/01902149109064331","article-title":"Effect of long-term cigarette smoke exposure on pulmonary vascular structure and function in the guinea pig","volume":"17","author":"Wright","year":"1991","journal-title":"Exp Lung Res"},{"key":"10.1016\/j.rmr.2017.11.005_bib0375","doi-asserted-by":"crossref","first-page":"395","DOI":"10.4103\/2045-8932.105027","article-title":"Smoking: is it a risk factor for pulmonary vascular diseases?","volume":"2","author":"Weissmann","year":"2012","journal-title":"Pulm Circ"},{"key":"10.1016\/j.rmr.2017.11.005_bib0380","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.humpath.2006.11.022","article-title":"Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases","volume":"38","author":"Dorfm\u00fcller","year":"2007","journal-title":"Hum Pathol"},{"key":"10.1016\/j.rmr.2017.11.005_bib0385","first-page":"2347","article-title":"Pulmonary veno-occlusive disease and scleroderma associated pulmonary hypertension","volume":"33","author":"Johnson","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rmr.2017.11.005_bib0390","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1183\/09031936.00081009","article-title":"Beyond arterial remodelling: pulmonary venous and cardiac involvement in patients with systemic sclerosis-associated pulmonary arterial hypertension","volume":"35","author":"Dorfm\u00fcller","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2017.11.005_bib0395","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1002\/art.34501","article-title":"Computed tomography findings of pulmonary venoocclusive disease in scleroderma patients presenting with precapillary pulmonary hypertension","volume":"64","author":"G\u00fcnther","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rmr.2017.11.005_bib0400","first-page":"809","article-title":"Sarcoidosis simulating pulmonary veno-occlusive disease","volume":"134","author":"Hoffstein","year":"1986","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.rmr.2017.11.005_bib0405","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1034\/j.1399-3003.2000.15b33.x","article-title":"Pulmonary veno-occlusive disease in pulmonary Langerhans\u2019 cell granulomatosis","volume":"15","author":"Hamada","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2017.11.005_bib0410","first-page":"664","article-title":"Pulmonary veno-occlusive disease. Another vascular disorder associated with human immunodeficiency virus infection?","volume":"118","author":"Ruchelli","year":"1994","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.rmr.2017.11.005_bib0415","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1183\/09031936.95.08111982","article-title":"Pulmonary veno-occlusive disease in a HIV-infected intravenous drug abuser","volume":"8","author":"Escamilla","year":"1995","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2017.11.005_bib0420","first-page":"472","article-title":"[Pulmonary veno-occlusive disease in a patient with HIV infection. A case report with autopsy findings]","volume":"22","author":"Hourseau","year":"2002","journal-title":"Ann Pathol"},{"key":"10.1016\/j.rmr.2017.11.005_bib0425","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/j.bbamcr.2014.04.006","article-title":"Keeping the eIF2\u00a0alpha kinase Gcn2\u00a0in check","volume":"1843","author":"Castilho","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.rmr.2017.11.005_bib0430","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1007\/s00018-012-1252-6","article-title":"The eIF2\u03b1 kinases: their structures and functions","volume":"70","author":"Donnelly","year":"2013","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.rmr.2017.11.005_bib0435","doi-asserted-by":"crossref","first-page":"E1124","DOI":"10.1152\/ajpendo.00080.2013","article-title":"The eukaryotic initiation factor\u00a02\u00a0kinase GCN2\u00a0protects against hepatotoxicity during asparaginase treatment","volume":"305","author":"Wilson","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.rmr.2017.11.005_bib0440","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1378\/chest.13-2366","article-title":"EIF2AK4\u00a0mutations in pulmonary capillary hemangiomatosis","volume":"145","author":"Best","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2017.11.005_bib0445","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1093\/eurheartj\/ehr160","article-title":"Early detection of pulmonary vascular disease in pulmonary arterial hypertension: time to move forward","volume":"32","author":"Lau","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.rmr.2017.11.005_bib0450","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.lpm.2009.09.013","article-title":"Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis","volume":"39","author":"Montani","year":"2010","journal-title":"Presse Med"},{"key":"10.1016\/j.rmr.2017.11.005_bib0455","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMra040291","article-title":"Treatment of pulmonary arterial hypertension","volume":"351","author":"Humbert","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2017.11.005_bib0460","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1161\/CIRCULATIONAHA.104.488486","article-title":"Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension","volume":"111","author":"Sitbon","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.rmr.2017.11.005_bib0465","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2214\/ajr.183.1.1830065","article-title":"Pulmonary hypertension: CT of the chest in pulmonary venoocclusive disease","volume":"183","author":"Resten","year":"2004","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.rmr.2017.11.005_bib0470","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1183\/09031936.00088914","article-title":"Mechanisms of exertional dyspnoea in pulmonary veno-occlusive disease with EIF2AK4\u00a0mutations","volume":"44","author":"Laveneziana","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2017.11.005_bib0475","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1183\/09031936.00097911","article-title":"Ventilation\/perfusion lung scan in pulmonary veno-occlusive disease","volume":"40","author":"Seferian","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2017.11.005_bib0480","first-page":"1671","article-title":"Pulmonary veno-occlusive disease: a case series and new observations","volume":"118","author":"Holcomb","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2017.11.005_bib0485","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1161\/CIRCULATIONAHA.114.006974","article-title":"Advances in therapeutic interventions for patients with pulmonary arterial hypertension","volume":"130","author":"Humbert","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.rmr.2017.11.005_bib0490","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/eurheartj\/ehp022","article-title":"A meta-analysis of randomized controlled trials in pulmonary arterial hypertension","volume":"30","author":"Gali\u00e8","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.rmr.2017.11.005_bib0495","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1183\/09031936.00017809","article-title":"Cautious epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive disease","volume":"34","author":"Montani","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2017.11.005_bib0500","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1164\/ajrccm.157.5.9708065","article-title":"Pulmonary edema complicating continuous intravenous prostacyclin in pulmonary capillary hemangiomatosis","volume":"157","author":"Humbert","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2017.11.005_bib0505","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0755-4982(05)84206-X","article-title":"Treatment of pulmonary arterial hypertension","volume":"34","author":"Montani","year":"2005","journal-title":"Presse Med"},{"key":"10.1016\/j.rmr.2017.11.005_bib0510","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1378\/chest.122.3.1096","article-title":"Effects of continuous\u00a0IV prostacyclin in a patient with pulmonary veno-occlusive disease","volume":"122","author":"Okumura","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2017.11.005_bib0515","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1253\/circj.CJ-11-0973","article-title":"Safety and efficacy of epoprostenol therapy in pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis","volume":"76","author":"Ogawa","year":"2012","journal-title":"Circ J"},{"key":"10.1016\/j.rmr.2017.11.005_bib0520","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1378\/chest.108.6.1754","article-title":"Effect of prostacyclin on microvascular pressures in a patient with pulmonary veno-occlusive disease","volume":"108","author":"Davis","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2017.11.005_bib0525","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0954-6111(99)90079-3","article-title":"Effects of inhaled nitric oxide and aerosolized iloprost in pulmonary veno-occlusive disease","volume":"93","author":"Hoeper","year":"1999","journal-title":"Respir Med"},{"key":"10.1016\/j.rmr.2017.11.005_bib0530","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.hlc.2005.07.002","article-title":"Sildenafil as adjunct therapy to high-dose epoprostenol in a patient with pulmonary veno-occlusive disease","volume":"15","author":"Kuroda","year":"2006","journal-title":"Heart Lung Circl"},{"key":"10.1016\/j.rmr.2017.11.005_bib0535","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1590\/S0100-879X2005000200006","article-title":"One-year follow-up of the effects of sildenafil on pulmonary arterial hypertension and veno-occlusive disease","volume":"38","author":"Barreto","year":"2005","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.rmr.2017.11.005_bib0540","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.2169\/internalmedicine.50.5035","article-title":"Lengthy diagnostic challenge in a rare case of pulmonary veno-occlusive disease: case report and review of the literature","volume":"50","author":"Ye","year":"2011","journal-title":"Intern Med"},{"key":"10.1016\/j.rmr.2017.11.005_bib0545","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1183\/09031936.00102609","article-title":"Goal-oriented therapy in pulmonary veno-occlusive disease: a word of caution","volume":"34","author":"Montani","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2017.11.005_bib0550","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1513\/AnnalsATS.201408-354OC","article-title":"Characteristics of patients with pulmonary venoocclusive disease awaiting transplantation","volume":"11","author":"Wille","year":"2014","journal-title":"Ann Am Thorac Soc"}],"container-title":["Revue des Maladies Respiratoires"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842517309786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842517309786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T19:52:47Z","timestamp":1535053967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0761842517309786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0761842517309786"],"URL":"https:\/\/doi.org\/10.1016\/j.rmr.2017.11.005","relation":{},"ISSN":["0761-8425"],"issn-type":[{"value":"0761-8425","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"La maladie veino-occlusive pulmonaire","name":"articletitle","label":"Article Title"},{"value":"Revue des Maladies Respiratoires","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmr.2017.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 SPLF. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}